{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T04:14:09Z","timestamp":1746677649685,"version":"3.40.5"},"reference-count":5,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1097\/cnd.0000000000000397","type":"journal-article","created":{"date-parts":[[2022,5,24]],"date-time":"2022-05-24T15:14:03Z","timestamp":1653405243000},"page":"230-231","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Pfizer mRNA COVID-19 Vaccination and Acute Inflammatory Demyelinating Polyneuropathy"],"prefix":"10.1097","volume":"23","author":[{"given":"Katrina A.","family":"Bernardo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajay","family":"Misra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250507","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med."},{"key":"R2-20250507","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/brain\/awaa444","article-title":"Special Commentary: COVID-19 vaccine and Guillian-Barre syndrome: let's not leap to associations","volume":"144","author":"Lunn","year":"2020","journal-title":"Brain."},{"key":"R3-20250507","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ana.26144","article-title":"Guillian-Barre syndrome variant occurring after SARS-CoV-2 vaccination","volume":"90","author":"Allen","year":"2021","journal-title":"Ann Neurol."},{"key":"R4-20250507","doi-asserted-by":"crossref","first-page":"e01143","DOI":"10.1016\/j.idcr.2021.e01143","article-title":"Guillain-Barre syndrome following the first dose of SARS-CoV-2 vaccine: a temporal occurrence, no a causal association","volume":"24","author":"Ogbebor","year":"2021","journal-title":"IDCases."},{"key":"R5-20250507","first-page":"13426","article-title":"Neurological complications of COVID-19: Guillian-Barre syndrome following pfizer COVID-19 vaccine","volume":"13","author":"Waheed","year":"2021","journal-title":"Cureus."}],"container-title":["Journal of Clinical Neuromuscular Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CND.0000000000000397","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T21:03:52Z","timestamp":1746651832000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CND.0000000000000397"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":5,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/cnd.0000000000000397","relation":{},"ISSN":["1522-0443"],"issn-type":[{"type":"print","value":"1522-0443"}],"subject":[],"published":{"date-parts":[[2022,6]]}}}